Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major health problem. Since 2011, anti-HCV therapy with availability of direct-acting antiviral drugs has revolutionized the clinical response and paved the way to eradication strategies. However, despite th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Mol Hepatol
Main Authors: Marascio, Nadia, Quirino, Angela, Barreca, Giorgio Settimo, Galati, Luisa, Costa, Chiara, Pisani, Vincenzo, Mazzitelli, Maria, Matera, Giovanni, Liberto, Maria Carla, Focà, Alfredo, Torti, Carlo
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association for the Study of the Liver 2019
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435970/
https://ncbi.nlm.nih.gov/pubmed/30669818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2018.0061
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki